Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle.

Daigle D, Gradoville L, Tuck D, Schulz V, Wang'ondu R, Ye J, Gorres K, Miller G.

J Virol. 2011 Jun;85(11):5628-43. doi: 10.1128/JVI.02659-10. Epub 2011 Mar 16.

3.

Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors.

Daigle D, Megyola C, El-Guindy A, Gradoville L, Tuck D, Miller G, Bhaduri-McIntosh S.

J Virol. 2010 Jan;84(2):993-1004. doi: 10.1128/JVI.01745-09. Epub 2009 Nov 4.

4.

Stimulus duration and response time independently influence the kinetics of lytic cycle reactivation of Epstein-Barr virus.

Countryman J, Gradoville L, Bhaduri-McIntosh S, Ye J, Heston L, Himmelfarb S, Shedd D, Miller G.

J Virol. 2009 Oct;83(20):10694-709. doi: 10.1128/JVI.01172-09. Epub 2009 Aug 5.

5.
7.

Lytic cycle switches of oncogenic human gammaherpesviruses.

Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L.

Adv Cancer Res. 2007;97:81-109. Review.

PMID:
17419942
8.

N-linked glycosylation is required for optimal function of Kaposi's sarcoma herpesvirus-encoded, but not cellular, interleukin 6.

Dela Cruz CS, Lee Y, Viswanathan SR, El-Guindy AS, Gerlach J, Nikiforow S, Shedd D, Gradoville L, Miller G.

J Exp Med. 2004 Feb 16;199(4):503-14.

9.

Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.

Gradoville L, Kwa D, El-Guindy A, Miller G.

J Virol. 2002 Jun;76(11):5612-26.

10.
11.
12.
13.

Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G.

J Virol. 1999 Mar;73(3):2232-42.

14.

A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus.

Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G.

Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10866-71.

15.

Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen.

Lin SF, Sun R, Heston L, Gradoville L, Shedd D, Haglund K, Rigsby M, Miller G.

J Virol. 1997 Apr;71(4):3069-76.

17.

Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.

Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y.

J Virol. 1997 Jan;71(1):314-24.

18.

Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21).

Serio TR, Angeloni A, Kolman JL, Gradoville L, Sun R, Katz DA, Van Grunsven W, Middeldorp J, Miller G.

J Virol. 1996 Nov;70(11):8047-54.

19.

Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus.

Sun R, Lin SF, Gradoville L, Miller G.

Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11883-8.

20.

Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.

Kolman JL, Taylor N, Gradoville L, Countryman J, Miller G.

J Virol. 1996 Mar;70(3):1493-504.

21.

Activation of the Epstein-Barr virus BMRF1 and BZLF1 promoters by ZEBRA in Saccharomyces cerevisiae.

Countryman JK, Heston L, Gradoville L, Himmelfarb H, Serdy S, Miller G.

J Virol. 1994 Nov;68(11):7628-33.

22.

Comparing regions of the Epstein-Barr virus ZEBRA protein which function as transcriptional activating sequences in Saccharomyces cerevisiae and in B cells.

Miller G, Himmelfarb H, Heston L, Countryman J, Gradoville L, Baumann R, Chi T, Carey M.

J Virol. 1993 Dec;67(12):7472-81.

23.

Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.

Carey M, Kolman J, Katz DA, Gradoville L, Barberis L, Miller G.

J Virol. 1992 Aug;66(8):4803-13.

25.

Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

Grogan E, Jenson H, Countryman J, Heston L, Gradoville L, Miller G.

Proc Natl Acad Sci U S A. 1987 Mar;84(5):1332-6.

26.

Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

Grogan EA, Summers WP, Dowling S, Shedd D, Gradoville L, Miller G.

Proc Natl Acad Sci U S A. 1983 Dec;80(24):7650-3.

27.

Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.

Andiman W, Gradoville L, Heston L, Neydorff R, Savage ME, Kitchingman G, Shedd D, Miller G.

J Infect Dis. 1983 Dec;148(6):967-77.

PMID:
6317774
28.

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Rabson M, Gradoville L, Heston L, Miller G.

J Virol. 1982 Dec;44(3):834-44.

29.

Genome of a mononucleosis Epstein-Barr virus contains DNA fragments previously regarded to be unique to Burkitt's lymphoma isolates.

Fischer DK, Miller G, Gradoville L, Heston L, Westrate MW, Maris W, Wright J, Brandsma J, Summers WC.

Cell. 1981 May;24(2):543-53.

PMID:
6263500

Supplemental Content

Loading ...
Support Center